Technical Description
The present invention offers a novel bioink for 3D bioprinting, made from two biopolymers and a crosslinking agent in an aqueous solution.
Problems Addressed
- High Cost
- Time-Consuming
- Complex Psyllium Extraction Processes
- Limited Cell-Adhesion Capability
Tech Features
- Better Compressive Strength
- High Swelling Property
- Enhanced Cell Proliferation
- Improved Viscosity-Shear Rate Relation
- Broad Applications
- Direct Psyllium Usage
Target Audience
- Biotechnology and Biomedical Industry
- Pharmaceutical Industry
- Cosmetics Industry
- Regenerative Medicine Industry
- Research and Development
Tech ID: P06-1236 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
